Search results for "Liver"

showing 10 items of 4961 documents

Hepatic Sinusoidal Dilatation: A Review of Causes With Imaging-Pathologic Correlation.

2016

Hepatic sinusoids are vascular conduits connecting the portal triad with the central vein. Multiple conditions can lead to sinusoidal dilatation and congestion with resultant stasis of blood within the lumen. The altered hemodynamics associated with hepatic sinusoidal dilatation generally result in heterogeneous enhancement of the hepatic parenchyma on contrast-enhanced computed tomography and magnetic resonance imaging, a pattern often described as “mosaic” enhancement. In this article, we review the causes of hepatic sinusoidal dilatation and the imaging manifestations on contrast-enhanced computed tomography and magnetic resonance.

medicine.medical_specialtyPathologyPortal triadHemodynamicsLumen (anatomy)Contrast MediaComputed tomographyHepatic Veins030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinePathologic correlationmedicineHumansRadiology Nuclear Medicine and imagingHemodynamicmedicine.diagnostic_testbusiness.industryLiver DiseaseLiver DiseasesHemodynamicsMagnetic resonance imagingMagnetic Resonance Imagingmedicine.anatomical_structureLiverHepatic parenchyma030220 oncology & carcinogenesisHepatic VeinRadiologyTomographybusinessTomography X-Ray ComputedHumanDilatation PathologicSeminars in ultrasound, CT, and MR
researchProduct

Liver Function Test Abnormalities in Patients with Inflammatory Bowel Diseases: A Hospital-based Survey

2014

Background and Aims Inflammatory bowel diseases (IBD) are frequently associated with altered liver function tests (LFTs). The causal relationship between abnormal LFTs and IBD is unclear. The aim of our study was to evaluate the prevalence and etiology of LFTs abnormalities and their association with clinical variables in a cohort of IBD patients followed up in a single center. Materials and Methods A retrospective review was undertaken of all consecutive IBD in- and outpatients routinely followed up at a single referral center. Clinical and demographic parameters were recorded. Subjects were excluded if they had a previous diagnosis of chronic liver disease. LFT abnormality was defined as …

medicine.medical_specialtyPathologySettore MED/09 - Medicina Internadrug-induced hepatotoxicityChronic liver diseaseInflammatory bowel diseaseGastroenterologyCholestasisinflammatory bowel diseaseInternal medicinemedicinelcsh:RC799-869Original Researchfatty liverLiver injurymedicine.diagnostic_testbusiness.industryFatty liverGastroenterologymedicine.diseaseCohortEtiologylcsh:Diseases of the digestive system. Gastroenterologyliver function testsbusinessLiver function testsClinical Medicine Insights: Gastroenterology
researchProduct

Solid organ transplantation for non-TTR hereditary amyloidosis: report from the 1st International Workshop on the Hereditary Renal Amyloidoses.

2012

Fibrinogen A α-chain (AFib) and apolipoprotein AI (AApoAI) amyloidosis due to variants in the AFib and ApoAI genes are the most common types of hereditary amyloidosis in Europe and the United States. Liver is the exclusive source of the aberrant amyloidogenic protein in AFib and responsible for supplying approximately half of the circulating variant ApoAI. Nephrotic syndrome and renal impairment due to renal amyloidosis are common disease manifestations; however, recent research provides evidence to support a more diverse and systemic disease phenotype, which in turn has implications in the management of the hereditary amyloidoses with solid organ transplantation and, in particular, liver t…

medicine.medical_specialtyPathologySystemic diseasemedicine.medical_treatmentLiver transplantationOrgan transplantationRenal amyloidosisInternal MedicineMedicineHumansbiologyApolipoprotein A-Ibusiness.industryAmyloidosisFibrinogenOrgan Transplantationmedicine.diseaseLiver TransplantationTransplantationTransthyretinTreatment OutcomeImmunologybiology.proteinbusinessNephrotic syndromeAmyloidosis FamilialAmyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
researchProduct

2006

medicine.medical_specialtyPathologybusiness.industryGeneral Physics and AstronomyCell BiologyIn situ hybridizationLiver carcinomaStructural BiologyMolecular geneticsImmunohistochemistryMedicineGeneral Materials SciencePancreatic carcinomabusinessMicron
researchProduct

The changing scenario of hepatocellular carcinoma in Italy: an update

2021

Background and aims: Epidemiology of hepatocellular carcinoma (HCC) is changing in most areas of the world. This study aimed at updating the changing scenario of aetiology, clinical presentation, management and prognosis of HCC in Italy during the last 15 years. Methods: Retrospective analysis of the Italian Liver Cancer (ITA.LI.CA) database included 6034 HCC patients managed in 23 centres from 2004 to 2018. Patients were divided into three groups according to the date of cancer diagnosis (2004-2008, 2009-2013 and 2014-2018). Results: The main results were: (i) a progressive patient ageing; (ii) a progressive increase of non-viral cases and, particularly, of ‘metabolic’ and ‘metabolic + alc…

medicine.medical_specialtyPediatricsCarcinoma HepatocellularRadiofrequency ablationmedicine.medical_treatmentSettore MED/12 - GASTROENTEROLOGIAsurvivalepidemiology; hepatocellular carcinoma; survival; treatment; Humans; Italy; Neoplasm Staging; Retrospective Studies; Carcinoma Hepatocellular; Liver Neoplasmslaw.invention03 medical and health sciences0302 clinical medicinelawRetrospective StudieEpidemiologyMedicineHumansNeoplasm StagingRetrospective StudiesHepatologytreatmentbusiness.industryLiver NeoplasmsCarcinomaSettore MED/09 - MEDICINA INTERNACancerHepatocellularhepatocellular carcinomamedicine.diseaseCalendar periodItaly030220 oncology & carcinogenesisHepatocellular carcinomaEtiologyepidemiology; hepatocellular carcinoma; survival; treatment030211 gastroenterology & hepatologyepidemiologyPercutaneous ethanol injectionbusinessLiver cancer
researchProduct

The Italian experience on paediatric liver transplantation: 1988-1999 report

2002

Abstract Background. Liver transplantation is the treatment of choice for end-stage liver disease in both adult and paediatric patients. The Italian experience in paediatric liver transplantation during the period 1988–1999 is reported herein. Patients and methods. This report concerns 228 liver transplantations performed in 207 patients (100 male, 107 female, mean age 5.1±4.4 years) in 11 Italian centres. The mean waiting time on the transplantation list was 6. 1±8.9 months and the main indications for the procedure were biliary atresia, inborn metabolic disorders, liver cirrhosis, liver neoplasms, Alagille syndrome, and fulminant hepatic failure. Results. The cumulative survival rate was …

medicine.medical_specialtyPediatricsCirrhosisLiver transplantationHepatologybusiness.industrymedicine.medical_treatmentGastroenterologyLiver transplantationmedicine.diseaseSurgeryTransplantationLiver diseaseFulminant hepatic failureSurvival analysiBiliary atresiaAlagille syndromePaediatric ageMedicinebusinessSurvival rate
researchProduct

Why are Cochrane hepato-biliary reviews undervalued by physicians as an aid for clinical decision-making?

2009

Abstract Background Cochrane systematic reviews are of higher quality than reviews published in scientific journals, yet are used less than other sources for clinical decision-making. Aim To assess whether the characteristics of the Cochrane systematic reviews can account for their scant use by physicians. Materials and methods We analysed the 87 Cochrane hepato-biliary reviews dealing with therapeutic topics posted in the Cochrane Database of Systematic Reviews through December 2008, which we classified according to four characteristics: empty reviews; outdated reviews; content of reviews; implications for practice. Results Six empty reviews found no eligible randomised trials and six foun…

medicine.medical_specialtyPediatricsEvidence-Based MedicineHepatologybusiness.industryBiliary Tract DiseasesLiver DiseaseseducationGastroenterologyAlternative medicinePsychological interventionReview Literature as TopicSystematic reviewClinical decision makingFamily medicinemedicineHumansbusinessDigestive and Liver Disease
researchProduct

Goitrous congenital hypothyroidism in a twin pregnancy causing respiratory obstruction at birth: Implications for management

2006

We report a twin pregnancy complicated by fetal goitrous hypothyroidism secondary to dyshormonogenesis caused by thyroglobulin deficiency. Antenatal treatment with intra-amniotic thyroxine was considered but not performed, given the late gestational age at diagnosis and the multiple nature of the pregnancy. Both twins developed airway obstruction at delivery, requiring intubation and ventilation. We review the literature and describe the practical issues relating to the antenatal assessment and perinatal management of fetal goitre.

medicine.medical_specialtyPediatricsGoiterThyroglobulinPregnancyPrenatal DiagnosisCongenital HypothyroidismDiseases in TwinsmedicineHumansTwin PregnancyPregnancyFetusThyroglobulin DeficiencyGoiterbusiness.industryInfant NewbornGestational ageGeneral MedicineAirway obstructionDelivery Obstetricmedicine.diseaseMagnetic Resonance ImagingSurgeryCongenital hypothyroidismAirway ObstructionPediatrics Perinatology and Child HealthFemalebusinessActa Paediatrica
researchProduct

The dilemma for patients with chronic hepatitis C: treat now or warehouse?

2013

Dual therapy with peginterferon and ribavirin, the only treatent for chronic hepatitis C available In Italy and in many other ountries worldwide up to 2013, obtains satisfactory response ates in infections with hepatitis C virus (HCV) genotype 2, but far rom optimal for other genotypes [1,2]. Eradication requires 6–12 onths of therapy, with significant inconvenience for patients: dverse reactions force premature termination in about 20% of atients and reduced the quality of life for almost all who persist n treatment. In view of the important and prolonged side effects, nterferon-based treatment is perceived as a nightmare by many symptomatic,well-being, socially activepatients (the largema…

medicine.medical_specialtyPediatricsTime FactorsProlineHepatitis C virusAlpha interferonmedicine.disease_causeAntiviral AgentsTelaprevirPolyethylene Glycolschemistry.chemical_compoundLiver diseaseBoceprevirDrug DiscoveryRibavirinmedicineHumansProtease InhibitorsAdverse effectWatchful WaitingDrug CarriersHepatologybusiness.industryRibavirinGastroenterologyInterferon-alphaHepatitis C Chronicmedicine.diseaseSurgeryEastern europeanchemistryHCVDrug Therapy CombinationbusinessOligopeptidesmedicine.drugDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Octaplex in routine clinical use for prophylaxis and therapy of bleeding in patients with prothrombin complex factor deficiency

2007

Octaplex is a new prothrombin complex concentrate that is indicated for treatment or perioperative prophylaxis of bleeding in patients with deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin K antagonists or by liver failure, when rapid correction of bleeding is required. The study was conducted to demonstrate both prevention of bleeding and achievement of haemostasis in acute bleeding and to obtain further information about the safety of administration of Octaplex.

medicine.medical_specialtyPediatricsbusiness.industryLiver failurePerioperativeAcute bleedingVitamin kCritical Care and Intensive Care MedicineProthrombin complex concentrateGastroenterologyCoagulationInternal medicinePoster PresentationmedicineIn patientbusinessPROTHROMBIN COMPLEXmedicine.drugCritical Care
researchProduct